Non-Surgical Management of
Knee Osteoarthritis

Why non-surgical care comes first

Knee osteoarthritis is a slow, mechanical and biological process — progressive loss of articular cartilage, changes in the underlying bone, and low-grade joint inflammation — that develops over years to decades. Because it is a whole-joint condition without a cure, treatment is aimed at reducing pain and improving function, not reversing the underlying disease. For the large majority of patients, especially those with mild-to-moderate radiographic changes, non-surgical treatment is not a stalling tactic before "the real treatment" — it is the treatment, and it works for a meaningful proportion of people well enough that surgery never becomes necessary.

Major guideline bodies are unusually consistent on this point. Both the 2019 OARSI guidelines and the third-edition AAOS clinical practice guideline on knee osteoarthritis (non-arthroplasty) place structured exercise, weight management, and patient education at the center of initial care, with pharmacological and injection-based treatments as adjuncts — not replacements — for these core measures.

Exercise: the best-supported treatment that isn't a pill or injection

Of everything discussed in this article, land-based therapeutic exercise has the deepest evidence base. A Cochrane systematic review (Fransen et al., 2015) pooling 54 randomised trials and nearly 4,000 participants found that exercise produced a moderate, statistically significant reduction in pain and improvement in physical function immediately after treatment, with benefit generally sustained for 2–6 months after formal sessions ended. No specific exercise type — strengthening, aerobic, or balance-focused — was clearly superior to the others; the consistent finding was that structured, supervised programs outperformed unsupervised or no exercise.

This matters practically: exercise for knee OA is not about "toughing it out" through pain, nor is it a single prescribed routine. A physiotherapist-guided program that progressively strengthens the quadriceps and hip muscles, improves range of motion, and is adjusted as symptoms change tends to produce better and more durable results than a generic handout of exercises done alone.

Weight management: modest weight loss, measurable joint benefit

For overweight or obese patients, weight loss is one of the few interventions that changes the mechanical environment of the knee, not just the symptoms. Each kilogram of body weight removes roughly 4 kg of load across the knee during walking, which compounds over tens of thousands of steps per day.

Medications and injections: where the evidence gets more mixed

Oral and topical non-steroidal anti-inflammatory drugs (NSAIDs) have the strongest evidence among pharmacological options and are generally recommended as first-line medication, with topical NSAIDs preferred where practical because of a lower systemic side-effect burden — particularly relevant for older patients or those with gastrointestinal or cardiovascular risk factors. Acetaminophen (paracetamol) is commonly used but guideline support for it has weakened over successive updates, as trial data show only a small effect size over placebo.

Injection-based treatments are where public expectations and the trial evidence diverge most.

Treatment	Typical guideline stance	What the evidence shows
Hyaluronic acid	Not recommended for routine use (AAOS); conditional/inconsistent across guidelines	Modest benefit over placebo in meta-analyses; effect sizes generally fall below the threshold considered clinically meaningful
Corticosteroid	Short-term option for symptom flares; not recommended for repeated long-term use	Effective for short-term pain relief; repeated injections over 2 years associated with greater cartilage volume loss than placebo, with no added pain benefit at 2 years (McAlindon et al., 2017)
PRP (platelet-rich plasma)	Not yet part of most core guideline recommendations; growing but heterogeneous evidence	Some trials show benefit over hyaluronic acid, but preparation methods vary widely between studies, making results hard to generalise
Structured exercise	Core treatment — recommended for nearly all patients	Consistent, moderate benefit for pain and function across dozens of RCTs

Bracing (particularly unloader braces for OA concentrated in one compartment of the knee) and orthotic insoles are sometimes recommended as adjuncts, but the evidence for meaningful, durable benefit is weaker and more mixed than for exercise or weight loss; they are reasonable to trial for a specific mechanical pattern of pain but shouldn't be expected to substitute for the core treatments.

When non-surgical care isn't enough

Non-surgical treatment is not meant to be pursued indefinitely regardless of outcome. A reasonable trial — typically several months of consistent, structured exercise combined with weight management where relevant, plus judicious use of medication — gives a genuine sense of whether these measures are controlling symptoms. If pain and function remain significantly limiting despite this, particularly with radiographic evidence of advanced joint space narrowing, that is the point at which a surgical opinion becomes a reasonable next step, not a failure of the non-surgical approach.

It's also worth being realistic about what non-surgical treatment cannot do: it does not regenerate lost cartilage or reverse bone-on-bone arthritis. Its role is to manage symptoms and function for as long as that remains effective and to delay or, for some patients, avoid the need for joint replacement altogether — which is a legitimate and valuable goal in its own right, not just a waiting room for surgery.